Jane Street »

Innate Pharma shares owned by Jane Street

Quarter-by-quarter ownership of Innate Pharma (IPHA) shares owned by Jane Street from 13F filings

Historical chart of Jane Street investment in Innate Pharma

Tip: Access up to 7 years of quarterly data

All positions including Innate Pharma held by Jane Street consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Innate Pharma by Jane Street

Quarter filed Position value Share count Share price at filing
2025-12-31 $162k 93k 1.75
2024-03-31 $42k 15k 2.88
2022-03-31 $127k 38k 3.37
2021-12-31 $67k 15k 4.55
2021-09-30 $151k 24k 6.18

More positions owned by Jane Street

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Meta Platforms Cl A Call Option (META)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Broadcom Call Option (AVGO)
Advanced Micro Devices Call Option (AMD)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)
Palantir Technologies Cl A Call Option (PLTR)

View all positions for Jane Street

Top funds holding Innate Pharma

Jane Street
Lion Point Capital
Old Mission Capital
Citadel Advisors
Rhumbline Advisers
GAMMA Investing
UBS Group
Farther Finance Advisors
SageView Advisory Group
Barclays

View all funds holding Innate Pharma